The microbiome bone axis in osteomyelitis: integrating evidence from bone oral and gut microbiota

Chanon Kunasol , Chaloemwut Piyaphattachai , Jirawat Saengsin , Nipon Chattipakorn , Siriporn C. Chattipakorn

Microbiome Research Reports ›› 2026, Vol. 5 ›› Issue (3) : 23

PDF
Microbiome Research Reports ›› 2026, Vol. 5 ›› Issue (3) :23 DOI: 10.20517/mrr.2026.63
Review
The microbiome bone axis in osteomyelitis: integrating evidence from bone oral and gut microbiota
Author information +
History +
PDF

Abstract

Osteomyelitis is an inflammatory bone disorder that includes both infectious and noninfectious forms and remains a major cause of bone destruction, impaired skeletal repair, and long-term disability. Although bacterial infection is the predominant cause, disease progression is influenced by interactions among microorganisms, host immunity, inflammation, and bone remodeling. This review critically evaluates current evidence from genome-wide association and Mendelian randomization studies, clinical investigations, and experimental animal models. Clinical studies demonstrate that osteomyelitic bone contains polymicrobial communities enriched with anaerobic and biofilm-forming bacteria, whereas oral microbial dysbiosis differs between chronic bacterial and chronic nonbacterial osteomyelitis. Experimental studies indicate that gut microbial dysbiosis is associated with impaired intestinal barrier function, altered microbial metabolites, systemic inflammation, and delayed bone repair. Current evidence therefore suggests that microbial communities detected at local sites are associated with infection, biofilm formation, and local inflammatory responses, whereas the gut microbiome may influence systemic immunity, inflammatory tone, and bone remodeling. Although microbiome-targeted interventions have shown beneficial effects in experimental models, current evidence remains largely associative, and mechanistic and longitudinal studies are limited. A better understanding of microbiome-host interactions may facilitate the development of microbiome-based strategies for the prevention and treatment of osteomyelitis.

Keywords

Osteomyelitis / dysbiosis / microbiome-bone axis / chronic bacterial osteomyelitis / chronic nonbacterial osteomyelitis

Cite this article

Download citation ▾
Chanon Kunasol, Chaloemwut Piyaphattachai, Jirawat Saengsin, Nipon Chattipakorn, Siriporn C. Chattipakorn. The microbiome bone axis in osteomyelitis: integrating evidence from bone oral and gut microbiota. Microbiome Research Reports, 2026, 5 (3) : 23 DOI:10.20517/mrr.2026.63

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Zhao Y.Chronic non-bacterial osteomyelitis and autoinflammatory bone diseases.Clin Immunol2020;216:108458 PMCID:PMC7338233

[2]

Haşlak F,Gül Ü.Autoinflammatory bone diseases.Balkan Med J2025;42:5-13 PMCID:PMC11725671

[3]

Kremers HM,Ransom JE,Melton LJ 3rd.Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009.J Bone Joint Surg Am2015;97:837-45 PMCID:PMC4642868

[4]

Schmitt SK.Osteomyelitis.Infect Dis Clin North Am2017;31:325-38

[5]

Kavanagh N,Widaa A.Staphylococcal osteomyelitis: disease progression, treatment challenges, and future directions.Clin Microbiol Rev2018;31 PMCID:PMC5967688

[6]

Buch K,Brøns C.Chronic non-bacterial osteomyelitis: a review.Calcif Tissue Int2019;104:544-53

[7]

Yang X,Li S,Dong L.Chronic non-bacterial osteomyelitis presenting as fever of unknown origin in a child: a diagnostic pitfall.BMC Pediatr2026;26 PMCID:PMC13520339

[8]

Brady RA,Calhoun JH,Shirtliff ME.Osteomyelitis and the role of biofilms in chronic infection.FEMS Immunol Med Microbiol2008;52:13-22

[9]

Díaz-Velis L,Roach F.Metagenomic and ribosomal transcript profiles of diabetic foot osteomyelitis in Hispanic patients: underestimated bacteria in biofilm persistence.Front Cell Infect Microbiol2025;15:1729196 PMCID:PMC12892099

[10]

Rausch P,Baines JF.Analysis of the fecal and oral microbiota in chronic recurrent multifocal osteomyelitis.Arthritis Res Ther2022;24:54 PMCID:PMC8862485

[11]

Asten SA,Peters EJ,Kim PJ.The microbiome of diabetic foot osteomyelitis.Eur J Clin Microbiol Infect Dis2016;35:293-8 PMCID:PMC4724363

[12]

Novince CM,Aartun JD.Commensal gut microbiota immunomodulatory actions in bone marrow and liver have catabolic effects on skeletal homeostasis in health.Sci Rep2017;7:5747 PMCID:PMC5515851

[13]

Nakazawa F,Poco SE.Description of Mogibacterium pumilum gen. nov., sp. nov. and Mogibacterium vescum gen. nov., sp. nov., and reclassification of Eubacterium timidum (Holdeman et al. 1980) as Mogibacterium timidum gen. nov., comb. nov.Int J Syst Evol Microbiol2000;50 Pt 2:679-88

[14]

Montalvany-Antonucci CC,de Arruda JAA.Short-chain fatty acids and FFAR2 as suppressors of bone resorption.Bone2019;125:112-21

[15]

Locatelli V.Effect of GH/IGF-1 on bone metabolism and Osteoporsosis.Int J Endocrinol2014;2014:235060 PMCID:PMC4132406

[16]

Yahara H,Takahashi M.Shotgun metagenomic analysis of saliva microbiome suggests Mogibacterium as a factor associated with chronic bacterial osteomyelitis.PLoS One2024;19:e0302569 PMCID:PMC11073694

[17]

Wang Y.Mendelian randomization analysis unveils causal relationships between skin microbiota and osteomyelitis.Arch Dermatol Res2025;317:797

[18]

Zhou Y,Zhu W.Microbial influences on calcium-phosphorus homeostasis and metabolic bone diseases: a bidirectional mendelian randomisation study on the gut-bone axis.J Cell Mol Med2025;29:e70491 PMCID:PMC11959414

[19]

Wang S,Sun W.The causal relationship between gut microbiota and nine infectious diseases: a two-sample Mendelian randomization analysis.Front Immunol2024;15:1304973 PMCID:PMC11266007

[20]

Zeng W,Liang X.Causal associations between human gut microbiota and osteomyelitis: a Mendelian randomization study.Front Cell Infect Microbiol2024;14:1338989 PMCID:PMC11035795

[21]

Lukens JR,Vogel P.Dietary modulation of the microbiome affects autoinflammatory disease.Nature2014;516:246-9 PMCID:PMC4268032

[22]

Bui TI,Mooney RA.Modulation of gut microbiota metabolism in obesity-related type 2 diabetes reduces osteomyelitis severity.Microbiol Spectr2022;10:e0017022 PMCID:PMC9045376

[23]

Zhou Y,Li CY.Effective mechanism of polysaccharides from Erxian herbal pair in promoting bone repair in traumatic osteomyelitis by activating osteoblast GPR41 and inhibiting the MEK/ERK/MAPK signalling axis.Int J Biol Macromol2025;307:141858

[24]

Do ADT,Perera R,Alrubaye A.Preliminary investigation of cecal microbiota in experimental broilers reared under the aerosol transmission lameness induction model.Animals (Basel)2025;15:3641 PMCID:PMC12729716

[25]

Zhao X,Wang Y.Association of antibiotic alterations in gut microbiota with decreased osseointegration of an intramedullary nail in mice with and without osteomyelitis.Front Endocrinol (Lausanne)2021;12:774257 PMCID:PMC8696274

[26]

Song M,Lv K,Shi J.A comprehensive review of pathology and treatment of staphylococcus aureus osteomyelitis.Clin Exp Med2025;25:131 PMCID:PMC12040984

[27]

Rong Z,Qin L.Immune escape of Staphylococcus aureus mediated by osteocyte lacuna-canalicular network leads to persistent and uncured bone infection.Front Cell Infect Microbiol2025;15:1592086 PMCID:PMC12171435

[28]

Zou M,Hu P.Analysis of the composition and functions of the microbiome in diabetic foot osteomyelitis based on 16S rRNA and metagenome sequencing technology.Diabetes2020;69:2423-39

[29]

Johani K,Bjarnsholt T.Understanding the microbiome of diabetic foot osteomyelitis: insights from molecular and microscopic approaches.Clin Microbiol Infect2019;25:332-9

[30]

Goda A,Michi Y,Harada K.Analysis of the factors affecting the formation of the microbiome associated with chronic osteomyelitis of the jaw.Clin Microbiol Infect2014;20:O309-17

[31]

Abu-Amer Y,Edwards J.Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.J Clin Invest1997;100:1557-65 PMCID:PMC508337

[32]

Galliera E,Logoluso N,Peretti G.Bone and infections: an osteoimmunological interplay.Int J Mol Sci2026;27:2602 PMCID:PMC13027165

[33]

Singh I,Rajni E.Hijacking of GPCRs and angiotensin-converting enzyme-2 in the pathophysiology of infectious diseases.J Renin Angiotensin Aldosterone Syst2026;27:14703203261455738

[34]

Lin J,Song L,Chu X.Unraveling the diabetic link to osteoporosis: novel insights from integrative bulk and single-cell transcriptomics.J Renin Angiotensin Aldosterone Syst2025;26:14703203251405957

[35]

Zeus M,Laws HJ,Borkhardt A.Results from a pilot study on the oral microbiome in children and adolescents with chronic nonbacterial osteomyelitis.Z Rheumatol2023;82:123-33 PMCID:PMC9981501

[36]

Casarin RC,Santos VR.Detection of Mogibacterium timidum in subgingival biofilm of aggressive and non-diabetic and diabetic chronic periodontitis patients.Braz J Microbiol2012;43:931-7

[37]

Li Q,Lu H.Porphyromonas, treponema, and mogibacterium promote IL8/IFNγ/TNFα-based pro-inflammation in patients with medication-related osteonecrosis of the jaw.J Oral Microbiol2020;13:1851112 PMCID:PMC7717612

[38]

Schnabel A,Beer M.Diagnosis, treatment and monitoring of chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) - evidence, practice and consensus-based recommendations from the German pediatric rheumatology society (GKJR).Autoimmun Rev2026;25:104075

[39]

Stø K,Holm K.Oral Eikenella as a potential new biomarker of symptomatic carotid atherosclerosis.J Oral Microbiol2026;18:2613521 PMCID:PMC12798661

[40]

Tang G,Munro CL,Mintz KP.EmaA, a potential virulence determinant of Aggregatibacter actinomycetemcomitans in infective endocarditis.Infect Immun2008;76:2316-24 PMCID:PMC2423096

[41]

Kawamoto D,Bueno-Silva B,Mayer MP.Alteration of homeostasis in Pre-osteoclasts induced by Aggregatibacter actinomycetemcomitans CDT.Front Cell Infect Microbiol2016;6:33 PMCID:PMC4815040

[42]

Gholizadeh P,Eslami H,Fakhrzadeh V.Oral pathogenesis of Aggregatibacter actinomycetemcomitans.Microb Pathog2017;113:303-11

[43]

Mandal RK,Wideman RF Jr,Kwon YM.Microbiota analysis of chickens raised under stressed conditions.Front Vet Sci2020;7:482637 PMCID:PMC7575692

[44]

Li Y,Kawashima Y.Identification of trypsin-degrading commensals in the large intestine.Nature2022;609:582-9 PMCID:PMC9477747

[45]

Song R,Zhang M.Potential and challenges of Christensenella minuta as a next-generation probiotic.Foods2025;14:4085 PMCID:PMC12692188

[46]

Lenoir M,Torres-Maravilla E.Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3.Gut Microbes2020;12:1-16 PMCID:PMC7567499

[47]

Wang T.TNF-α and IL-6: the link between immune and bone system.Curr Drug Targets2020;21:213-27

[48]

Jiang T,Wideman RF Jr,Pevzner I.Molecular survey of bacterial communities associated with bacterial chondronecrosis with osteomyelitis (BCO) in broilers.PLoS One2015;10:e0124403 PMCID:PMC4400152

[49]

Asnayanti A,Alharbi K.Inducing experimental bacterial chondronecrosis with osteomyelitis lameness in broiler chickens using aerosol transmission model.Poult Sci2024;103:103460 PMCID:PMC10846381

[50]

Zeng L,Luo Y,Sun L.The gut microbiota: emerging evidence in autoimmune and inflammatory diseases.Research (Wash D C)2026;9:1097 PMCID:PMC12868559

[51]

Shi H,Zhang JH.Gut Microbiota regulates brain-bone axis to influence osteoporosis pathogenesis and treatment.Research (Wash D C)2026;9:1178 PMCID:PMC12989651

[52]

Larsen JM.The immune response to Prevotella bacteria in chronic inflammatory disease.Immunology2017;151:363-74 PMCID:PMC5506432

[53]

Huang Y,Cai Z.Prevotella induces the production of Th17 cells in the colon of mice.J Immunol Res2020;2020:9607328 PMCID:PMC7657696

[54]

Archer AC,Halami PM.Lactobacillus fermentum MCC2759 and MCC2760 alleviate inflammation and intestinal function in high-fat diet-fed and streptozotocin-induced diabetic rats.Probiotics Antimicrob Proteins2021;13:1068-80 PMCID:PMC8342349

[55]

Liao W,Jia C.Lactobacillus rhamnosus LC-STH-13 ameliorates the progression of SLE in MRL/lpr mice by inhibiting the TLR9/NF-κB signaling pathway.Food Funct2025;16:475-86

[56]

Vaghef-Mehrabany E,Homayouni-Rad A,Asghari-Jafarabadi M.Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis.Nutrition2014;30:430-5

[57]

Yang Q,Cao J.Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages.Cell Death Differ2016;23:1850-61 PMCID:PMC5071574

[58]

Carriche GM,Stüve P.Regulating T-cell differentiation through the polyamine spermidine.J Allergy Clin Immunol2021;147:335-348.e11

[59]

Pirnes-Karhu S,Finnilä M,Uimari A.Overexpression of spermidine/spermine N1-acetyltransferase impairs osteoblastogenesis and alters mouse bone phenotype.Transgenic Res2015;24:253-65

[60]

Yamamoto T,Fujita H.The natural polyamines spermidine and spermine prevent bone loss through preferential disruption of osteoclastic activation in ovariectomized mice.Br J Pharmacol2012;166:1084-96 PMCID:PMC3417431

[61]

Lee MJ,Huang YP.Exogenous polyamines promote osteogenic differentiation by reciprocally regulating osteogenic and adipogenic gene expression.J Cell Biochem2013;114:2718-28

[62]

Yan J,Tsang K.Gut microbiota induce IGF-1 and promote bone formation and growth.Proc Natl Acad Sci U S A2016;113:E7554-63 PMCID:PMC5127374

PDF

2

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉